Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04546061 · ClinicalTrials.gov registry record · NA
Project Uplift: Substance Use and Mental Health Treatment for Young Sexual and Gender Minorities
A NA study of Substance Use and Mental Health, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 2
- Study locations
NCT04546061: Completed NA study of Substance Use and Mental Health, sponsored by Duke University.
NCT04546061 is a NA study of Substance Use and Mental Health that has completed, run by Duke University. The registered enrollment target is 112 participants, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04546061, a NA study of Substance Use and Mental Health, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study provides substance use and mental health treatment for young sexual and gender minority adults in Durham and Charlotte, NC and seeks to provide intensive wraparound services that address factors that influence substance use and mental health among this population such as minority stressors and lack of social support, housing instability, lack of access to affirmative health care, and limited job opportunities.
Primary Outcome
Addiction Severity Index collected via a computer assisted self-interviewing survey
Conditions Studied
Interventions
- BEHAVIORAL Project Uplift
Study Locations (2)
North Carolina
- Mecklenburg County Community Support Services - Charlotte
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2020-09-15 |
| Est. Completion | 2023-01-25 |
| Phase | NA |
What the finished NCT04546061 record still lists
NCT04546061 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Project Uplift is the first listed.
NCT04546061 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04546061 about?
NCT04546061 is a clinical study titled "Project Uplift: Substance Use and Mental Health Treatment for Young Sexual and Gender Minorities". This study provides substance use and mental health treatment for young sexual and gender minority adults in Durham and Charlotte, NC and seeks to provide intensive wraparound services that address factors that influence substance use and mental health among this population such as minority stressor...
What is the current status of trial NCT04546061?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2020-09-15. Estimated completion is 2023-01-25.
What conditions does trial NCT04546061 study?
This clinical trial studies the following conditions: Substance Use, Mental Health.
What interventions are being tested in trial NCT04546061?
The interventions under investigation include: Project Uplift (BEHAVIORAL).
Who is sponsoring clinical trial NCT04546061?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04546061 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04546061's enrollment target sits among peer trials
112 61st of 88 higher than 28 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI